Adrenal atrophy primary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Adrenal atrophy}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{reflis..." |
No edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenal atrophy}} | {{Adrenal atrophy}} | ||
{{CMG}}; {{AE}} {{MHP}} | |||
==Overview== | |||
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous [[corticosteroid]] drugs. | |||
==Primary prevention== | |||
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous [[corticosteroid]] drugs.<ref name="pmid26760044">{{cite journal |vauthors=Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ |title=Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline |journal=J Clin Endocrinol Metab |volume=101 |issue=2 |pages=364–89 |date=February 2016 |pmid=26760044 |pmc=4880116 |doi=10.1210/jc.2015-1710 |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | |||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:Endocrinology]] | |||
[[Category:Genetic disorders]] | |||
Latest revision as of 02:30, 10 June 2022
|
Adrenal atrophy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenal atrophy primary prevention On the Web |
|
American Roentgen Ray Society Images of Adrenal atrophy primary prevention |
|
Risk calculators and risk factors for Adrenal atrophy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.
Primary prevention
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.[1]
References
- ↑ Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (February 2016). "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 101 (2): 364–89. doi:10.1210/jc.2015-1710. PMC 4880116. PMID 26760044.